Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Lucid Diagnostics Inc.

LUCD•NASDAQ
Healthcare
Medical - Devices
$1.38
$-0.00(-0.36%)
U.S. Market is Open • 12:44

Lucid Diagnostics Inc. (LUCD) Stock Overview

Explore Lucid Diagnostics Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap138.4M
P/E Ratio-2.78
EPS (TTM)$-0.77
ROE-6.32%
Fundamental Analysis

AI Price Forecasts

1 Month$1.47
3 Months$1.42
1 Year Target$1.08

LUCD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Lucid Diagnostics Inc. (LUCD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 62.10, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.08.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.78 and a market capitalization of 138.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.45%
5-Day Change
11.48%
1-Month Change
12.40%
3-Month Change
33.33%
6-Month Change
32.04%
Year-to-Date (YTD) Change
21.43%
1-Year Change
-8.72%
3-Year Change
3.03%
5-Year Change
-88.44%
All-Time (Max) Change
-88.44%

Contact Information

https://www.luciddx.com
212 949 4319
One Grand Central Place, New York City, NY, 10165

Company Facts

720 Employees
IPO DateOct 14, 2021
CountryUS
Actively Trading

Frequently Asked Questions